Zovirax site receives FDA Warning Letter

Share this article:
The Zovirax (acyclovir) ointment Web site, along with a consumer STD awareness deck card, misleadingly suggest to consumers that the GlaxoSmithKline product may prevent transmission of genital herpes infections, according to an FDA Warning Letter. The agency says that neither substantial evidence nor clinical experience have demonstrated this claim.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Legal/Regulatory

This compelling e-book shares a wealth of insights designed to help members of sales forces connect with elusive HCPs. An expanded version has also been created that includes video interviews and other multimedia content. Click here for access.